Can a lash-growth serum like bimatoprost actually work for your scalp?

A serum approved by the FDA only for growing eyelashes naturally raises a compelling question: could it also work on the scalp? Hair loss is a widespread concern, and it's not unusual for people dealing with alopecia or gradual hair thinning to look beyond the standard options.

In this context, bimatoprost has caught attention as a possible treatment for scalp hair loss.

But how real is this possibility?

User Experiences: Can Bimatoprost Work for Scalp Hair Growth?

While bimatoprost is well known as an FDA-approved treatment for eyelash growth (marketed as Latisse), its potential for scalp hair regrowth has been a topic of increasing curiosity within the Tressless community. Here's a synthesis of user experiences and sentiment on this topic, based on discussions in the Tressless forum.

Interest Driven by Research

Several users point to laboratory research suggesting bimatoprost acts on hair follicles taken from the scalp. The study most often cited is Khidhir and colleagues (2013, FASEB Journal), which reported that bimatoprost increased hair production in cultured human scalp follicles and advanced hair regrowth in mice, and described the effect as receptor-mediated. That work drew attention from users looking for alternatives or additions to mainstream treatments like minoxidil or finasteride.

Early Experimentation and DIY Formulations

Posts such as "Bimatoprost 1% solution on scalp" document users mixing their own bimatoprost serums at concentrations far above the 0.03% ophthalmic strength. Some community members do this; it is unregulated, the concentrations have never been tested on the scalp in a published trial, and it carries a real risk of skin and eye side effects. There is no published human study comparing homemade bimatoprost solutions with minoxidil 5%, so claims of one out-performing the other are not supported by evidence. The community itself is cautious here, noting the limited human data and the risk of pigmentation changes.

Practical Barriers and Sourcing Issues

A recurring theme in threads such as "Bimatoprost research – does anyone know where to buy the powder?" is that pharmaceutical bimatoprost is a prescription product and is expensive. Some users describe looking for it outside the pharmacy supply chain. Material bought this way is not quality-controlled, its strength and purity are unverified, and using it is not something this site can advise on — a prescriber is the right route.

Effectiveness Compared to Other Treatments

Many users emphasize that bimatoprost is unlikely to replace finasteride or minoxidil. As seen in "Is latanoprost/bimatoprost actually that effective?", users report that bimatoprost may convert fine vellus hairs into thicker terminal hairs, particularly along the hairline. The prevailing view in those threads is that it works best as a supplement rather than a replacement — primarily because of its cost and the unknowns around long-term scalp efficacy.

Concerns About Side Effects

In posts like "Starting Bimatoprost! Hair time", users discuss side effects such as loss of fat around the eye socket and changes in eye and eyelid pigmentation. These are not only user concerns: the prescribing information for bimatoprost products lists periorbital fat atrophy, darkening of the eyelid skin, brown darkening of the iris that the label says is likely to be permanent, and eye redness among its known effects. That makes some users hesitant to apply it regularly over large areas of the scalp.

Combining with Other Treatments

There's growing interest in formulations combining bimatoprost with minoxidil and finasteride. Users in threads such as "New company bringing Minoxidil + Finasteride + Bimatoprost topical to market" speculate whether synergy between mechanisms might yield better results. No large-scale trial has tested that combination.

Can an eye medication deliver results on your scalp?

Bimatoprost is a synthetic analog of prostaglandin F2α, a compound the body uses to regulate a range of physiological processes, including the hair growth cycle. It became widely known as the active ingredient in Latisse, approved by the FDA in 2008 to treat eyelash hypotrichosis (inadequate eyelashes). Its effect there is attributed to prolonging the anagen phase of the hair follicle — the stage when hair actively grows. That mechanism led researchers to ask whether the same effect could be reproduced on the scalp, where hair loss usually follows hormonal, genetic, or inflammatory patterns. But the question isn't trivial. Scalp hair grows in a very different environment than eyelashes: higher follicular density, different environmental exposure, and a much longer, more complex growth cycle.

What does current science say?

Allergan, the company that developed Latisse, ran the largest scalp trials. Two phase 2 studies in men with androgenetic alopecia are registered on ClinicalTrials.gov: NCT01325337, which enrolled 307 men, and NCT01904721, which enrolled 244 men. Both have results posted to the registry. NCT01325337 was randomized and triple-masked, and tested three topical bimatoprost formulations against both a vehicle placebo and a 5% minoxidil active comparator. Neither trial produced a peer-reviewed journal publication, which is the main reason dermatologists treat the scalp data as preliminary. The registry entries are the primary public record of what was found. In NCT01325337, the mean 6-month change in target-area hair count was +6 to +13 hairs for the three bimatoprost formulations, +22 for minoxidil 5% and +4 for vehicle. In NCT01904721, the two bimatoprost solutions gained +9 and +13 hairs against +6 for vehicle.

The absence of published, peer-reviewed data has kept skepticism alive in the medical community. Without full data sets and independent review, it is hard to judge how meaningful the reported benefits were. On the laboratory side, Khidhir and colleagues (2013), publishing in the FASEB Journal, applied bimatoprost to cultured human scalp follicles and to mice. In mice, topical application stimulated the shift into anagen and accelerated fur growth; in cultured human follicles, hair production increased. These are laboratory and animal results, and they have limits: mouse follicular biology differs from human, mouse skin absorbs topicals more readily, and an isolated follicle in culture does not behave the way a follicle does in a living scalp. Those results were nonetheless the basis for taking the compound into human trials.

How different is scalp hair compared to eyelashes?

To answer the original question — can bimatoprost really work on the scalp? — one difference matters most. Eyelashes grow in a cycle of about three months. Scalp hair follows a much longer cycle, with the anagen phase lasting anywhere from two to six years. Any compound acting on that cycle has to do so in a sustained way to show a visible result.

The scalp also has a different hormonal environment. Androgenetic alopecia is linked to follicle sensitivity to dihydrotestosterone (DHT), a hormone that does not drive eyelash follicles. Success on the eyelid therefore does not predict success on the scalp, where the causes of hair loss are more complex.

Bimatoprost remains an experimental scalp treatment

No regulatory agency has approved bimatoprost for treating scalp hair loss. Used that way it is off-label and experimental. In the larger of Allergan's two registered phase 2 trials (NCT01325337, 307 men), every bimatoprost formulation produced a smaller 6-month hair-count gain (+6 to +13 hairs) than minoxidil 5% (+22); vehicle gained +4. The results were never published in a journal. Cost and the need for consistent, long-term application are further practical drawbacks. The long-term safety of applying bimatoprost to the scalp has not been established, and the documented ocular and periorbital effects listed on the product label are the reason that matters.

Conclusion: Is it worth trying bimatoprost on your scalp?

Using an eyelash serum on the scalp is an appealing idea, but the published clinical evidence is thin. Bimatoprost influences the hair follicle cycle in cultured follicles and in mice, but in the registered human scalp trials it did less than minoxidil 5%, and the available data do not support it as a treatment for scalp hair loss. On the published record it is unproven — an experimental compound rather than an established treatment.

Bimatoprost is a prescription medicine. Talk to a doctor or pharmacist before starting, stopping or combining bimatoprost, especially if you already use other topical or oral hair-loss treatments, or if you have any eye condition.

References

U.S. Food and Drug Administration. (2008). FDA approves Latisse to treat inadequate eyelashes. https://www.fda.gov/news-events/press-announcements/fda-approves-latisse-treat-inadequate-eyelashes

ClinicalTrials.gov. Safety and Efficacy Study of Bimatoprost in the Treatment of Men With Androgenic Alopecia. ClinicalTrials.gov Identifier: NCT01325337. https://clinicaltrials.gov/study/NCT01325337

ClinicalTrials.gov. A Safety and Efficacy Study of Bimatoprost in Men With Androgenic Alopecia (AGA). ClinicalTrials.gov Identifier: NCT01904721. https://clinicaltrials.gov/study/NCT01904721

Khidhir, K. G., Woodward, D. F., Farjo, N. P., Farjo, B. K., Tang, E. S., Wang, J. W., et al. (2013). The prostamide-related glaucoma therapy, bimatoprost, offers a novel approach for treating scalp alopecias. FASEB Journal, 27(2), 557–567. PMID: 23104985. https://pubmed.ncbi.nlm.nih.gov/23104985/

Tressless Community. (2021). Bimatoprost 1% solution on scalp. Retrieved from https://reddit.com/r/tressless/comments/q23mtm/bimatoprost_1_solution_on_scalp/

Tressless Community. (2021). Bimatoprost research – does anyone know where to buy the powder?. Retrieved from https://reddit.com/r/tressless/comments/psqc11/bimatoprost_research_does_anyone_where_to_buy_the/

Tressless Community. (2018). Interesting Study: Bimatoprost (Latisse) shows promise in combatting scalp alopecia. Retrieved from https://reddit.com/r/tressless/comments/9unot6/interesting_study_bimatoprost_latisse_shows/

Tressless Community. (2025). Starting Bimatoprost! Hair time. Retrieved from https://reddit.com/r/tressless/comments/1ieoceg/starting_bimatoprost_hair_time/

Tressless Community. (2020). New company bringing Minoxidil + Finasteride + Bimatoprost topical to market. Retrieved from https://reddit.com/r/tressless/comments/g2dvaj/new_company_bringing_minoxidil_finasteride/